Basir Eye health Research Center
  • Register
  • Login

Journal of Ophthalmic and Optometric Sciences

  • Home
  • About
    • About the Journal
    • Editorial Policies
    • Indexing & Abstracting
    • Privacy Statement
  • Current Issue
  • Archives
  • Editorial Team
  • Ethical Considerations
  • Copy Right Form
  • Author Guidelines
  • Submit Article
  • COPE Compliance
  • Contact
Advanced Search
  1. Home
  2. Archives
  3. Vol. 7 No. 1 (2023): Winter
  4. Case Reports

Vol. 7 No. 1 (2023)

January 2023

Self-withdrawal of Levetiracetam in a Patient with Epilepsy Leading to Blindness

  • Seyed Mohammad Masoud Shushtarian
  • Reza Pour Mazar

Journal of Ophthalmic and Optometric Sciences, Vol. 7 No. 1 (2023), 1 January 2023 , Page 28-30
https://doi.org/10.22037/joos.v7i1.44038 Published: 2023-01-01

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

A 27-year-old female patient was referred to Basir Eye Clinic in Tehran, Iran, following sudden total blindness in both eyes. She had a history of receiving various medications for different illnesses, including epilepsy. She reported sudden self-withdrawal of Levetiracetam. Within one week after discontinuing the medication, she completely lost vision in both eyes. A complete examination of the patient including visual evoked potential examination led to a diagnosis of cortical blindness.

Keywords:
  • Self-withdrawal
  • levebel
  • seizure
  • pdf

How to Cite

Shushtarian, S. M. M., & Pour Mazar , R. (2023). Self-withdrawal of Levetiracetam in a Patient with Epilepsy Leading to Blindness. Journal of Ophthalmic and Optometric Sciences, 7(1), 28–30. https://doi.org/10.22037/joos.v7i1.44038
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

Kocur I, Resnikoff S. Visual impairment and blindness in Europe and their prevention. Br J Ophthalmol. 2002;86(7):716-22.

Cumberland PM, Russell-Eggitt I, Rahi JS. Active surveillance of visual impairment due to adverse drug reactions: findings from a national study in the United Kingdom. Pharmacol Res Perspect. 2015;3(1):e00107.

Shushtarian SMM, Vahid Dastjerdi M. Total Blindness Following Anaphylactic Shock due to Co-Amoxiclav Treatment. Journal of Ophthalmic and Optometric Sciences. 2020;4(4):39-41.

Hu W, Chen L, Li H, Liu J. Eye disorders associated with newer antiepileptic drugs: A real-world disproportionality analysis of FDA adverse event reporting system. Seizure. 2022;96:66-73.

Hamed SA. Ocular dysfunctions and toxicities induced by antiepileptic medications: Types, pathogenic mechanisms, and treatment strategies. Expert Rev Clin Pharmacol. 2019;12(4):309-28.

Ogunsakin O, Tumenta T, Louis-Jean S, Mahbub A, Rabel P, Olupona T, et al. Levetiracetam Induced Behavioral Abnormalities in a Patient with Seizure Disorder: A Diagnostic Challenge. Case Rep Psychiatry. 2020;2020:8883802.

Zhang JF, Piryani R, Swayampakula AK, Farooq O. Levetiracetam-induced aggression and acute behavioral changes: A case report and literature review. Clin Case Rep. 2022;10(3):e05586.

Armijo JA, Adín J. Pharmacological basis for withdrawal of antiepileptic drugs. Rev Neurol. 2000;30(4):336-50. (Article in Spanish)

Jain A, Sankhe S. Hyperglycemia-induced seizures and blindness. Indian J Radiol Imaging. 2020;30(2):245-7.

Sadeh M, Goldhammer Y, Kuritsky A. Postictal blindness in adults. J Neurol Neurosurg

Psychiatry. 1983;46(6):566-9.

  • Abstract Viewed: 85 times
  • pdf Downloaded: 154 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact
Powered by OJSPlus